SIAP
MRNA icon

Sterling Investment Advisors (Pennsylvania)’s Moderna MRNA Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-775
Closed -$111K – 351
2022
Q2 		$111K Buy
775
+120
+18% +$17.2K 0.04% 172
2022
Q1 		$113K Buy
655
+325
+98% +$54.7K 0.03% 180
2021
Q4 		$84K Buy
330
+100
+43% +$29.2K 0.02% 210
2021
Q3 		$89K Sell
230
-10
-4% -$3.69K 0.03% 203
2021
Q2 		$56K Hold
240
– – 0.02% 245
2021
Q1 		$31K Buy
240
+190
+380% +$27.5K 0.01% 277
2020
Q4 		$5K Sell
50
-522
-91% -$52.8K ﹤0.01% 407
2020
Q3 		$40K Buy
572
+562
+5,620% +$39.2K 0.02% 234
2020
Q2 		$0 Buy
+10
New +$548 ﹤0.01% 430

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania)'s MRNA Position: Q3 2022 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Moderna (MRNA) in Q3 2022, closing a stake of 775 shares — an estimated $111K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in MRNA in Q2 2020 and held it in 9 quarters. The position peaked at $113K in Q1 2022. 916 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining Moderna position as of Q3 2022 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 775 Moderna shares in Q3 2022, an estimated $111K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Moderna in Q2 2020 and held it in 9 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s Moderna position peaked at $113K in Q1 2022.
  • 916 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2022, filed 3 Nov 2022.